|
Media Advisory 10-015
NSF Webcast: Getting a Grip on Stroke Treatment
Innovators present new device for removing blood clots in the brain
May 19, 2010
View a webcast featuring the SHELTER technology and its developers Vikram and Vallabh Janardhan.
A new surgical device--tested using silicone copies of human cadaver blood vessels--is poised to advance stroke treatment and revolutionize how the medical community evaluates new technologies. On Thursday, May 27, at 2:00 p.m. EDT, during a webcast hosted by the National Science Foundation, the developers of the net-like Insera SHELTERTM device will demonstrate how their technology filters and removes blood clots, and present the latest results from recent performance tests. Interventional neurologist Vallabh Janardhan and Insera engineer and CEO Vikram Janardhan will explain how SHELTERTM (which stands for Stroke Help using an Endo-Luminal Transcatheter Embolus Retrieval device) may be a safer alternative to the common "corkscrew" approach for strokes, which can release stroke-inducing debris. The researchers will also describe their uniquely accurate testing platform, one nearly identical to living human tissues--complete with aneurisms, atherosclerosis and "plaque"--which may supplant certain types of animal testing experiments. | Who: | Interventional neurologist Vallabh Janardhan and engineer Vikram Janardhan of Insera Therapeutics of Sacramento, Calif.
| | What: | Webcast demonstration of NSF Small Business Innovation Research (SBIR)-supported Insera SHELTERTM device.
| | When: | Thursday, May 27, 2010, at 2:00 p.m. EDT
| | Where: | Media are invited to participate in the webcast by phone or online at http://science360.gov/live/. (Note: the URL will only be live during the event.) Please contact Josh Chamot (jchamot@nsf.gov) for phone number and passcode information. Vallabh and Vikram Janardhan will respond to questions from the media throughout the webcast. |
Questions before and during the webcast can be directed to webcast@nsf.gov. May is National Stroke Awareness Month; learn more on the Centers for Disease Control and Prevention website. Insera is supported by NSF SBIR grant 0946099.
-NSF-
Media Contacts
Joshua A. Chamot, NSF (703) 292-7730 jchamot@nsf.gov
Program Contacts
Gregory T. Baxter, NSF (703) 292-7795 gbaxter@nsf.gov
Principal Investigators
Vallabh Janardhan, Insera Therapeutics (916) 849-0945 vallabh@inseratherapeutics.com
Co-Investigators
Vikram Janardhan, Insera Therapeutics (916) 849-0945 vikram@inseratherapeutics.com
The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2012, its budget was $7.0 billion. NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and other institutions. Each year, NSF receives about 50,000 competitive requests for funding, and makes about 11,500 new funding awards. NSF also awards about $593 million in professional and service contracts yearly.
 Get News Updates by Email
Useful NSF Web Sites:
NSF Home Page: http://www.nsf.gov
NSF News: http://www.nsf.gov/news/
For the News Media: http://www.nsf.gov/news/newsroom.jsp
Science and Engineering Statistics: http://www.nsf.gov/statistics/
Awards Searches: http://www.nsf.gov/awardsearch/
| 
